Companies / Information Technology
KLAC
KLA Corporation
Semiconductor Materials & Equipment
Semiconductor Materials & EquipmentAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health80
Growth60
Profitability94
Cash generation81
Balance sheet80
Dilution control84
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)28.9%Revenue growth (FY)11.7%Revenue CAGR (3y)9.0%Gross margin61.3%Operating margin—Net margin35.6%Free cash flow margin27.7%R&D / revenue11.3%Stock comp / revenue2.3%Net debt / operating cash flow1.02xCurrent ratio2.88Diluted share count change-1.3%
| Fiscal year ending | FY 2022-06 | FY 2023-06 | FY 2024-06 | FY 2025-06 | FY 2026-06 |
|---|---|---|---|---|---|
| Revenue | $9.2B | $10.5B | $9.8B | $12.2B | $13.6B |
| Gross profit | $5.6B | $6.3B | $5.9B | $7.4B | $8.3B |
| Net income | $3.3B | $3.4B | $2.8B | $4.1B | $4.8B |
| Operating cash flow | $3.3B | $3.7B | $3.3B | $4.1B | $4.1B |
| Capital expenditure | $307M | $342M | $277M | $335M | $376M |
| Free cash flow | $3.0B | $3.3B | $3.0B | $3.7B | $3.8B |
| R&D | $1.1B | $1.3B | $1.3B | $1.4B | $1.5B |
| Stock-based comp | $127M | $171M | $213M | $265M | $310M |
| Buybacks | $4.0B | $1.3B | $1.7B | $2.1B | $2.3B |
| Dividends | $639M | $733M | $773M | $905M | $1.1B |
| Cash | $1.6B | $1.9B | $2.0B | $2.1B | $1.6B |
| Total debt | $6.7B | $5.9B | $5.9B | $5.9B | $5.9B |
| Equity | $1.4B | $2.9B | $3.4B | $4.7B | $6.3B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.